Poor glycemic control attributable to insulin antibody in a fulminant type 1 diabetes patient under hemodialysis: successful treatment with double filtration plasmapheresis and prednisolone
Abstract Background Insulin antibody appears in approximately 40% of insulin users using human insulin and insulin analog formulations. Insulin antibody, characterized by high affinity and low insulin antibody binding capacity (% bound), rarely causes clinical problems including poor glycemic contro...
Main Authors: | Kentaro Wada, Haruhito A. Uchida, Yuko Wada |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Renal Replacement Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41100-017-0096-9 |
Similar Items
-
Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies
by: Danielle Brooks, MD, et al.
Published: (2021-09-01) -
Double Filtration Plasmapheresis Treatment of Refractory Multiple Sclerosis Relapsed on Fingolimod: A Case Report
by: Roberto De Masi, et al.
Published: (2020-10-01) -
Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis
by: Diego Curtò, et al.
Published: (2021-06-01) -
Clinical analysis of single filtration plasmapheresis using continuous renal replacement therapy machines in kidney transplantation
by: Eunsoo Lim, et al.
Published: (2017-06-01) -
TRADITIONAL AND CASCADE PLASMAPHERESIS IN ANTIBODY TITERS’ REDUCTION IN RENAL TRANSPLANT RECIPIENTS
by: A.V. Vatazin, et al.
Published: (2014-05-01)